Formulations of psilocin that have enhanced stability
US12097184B2 · kind B2 · utility
0Cited by
6References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 31, 2023 |
| Grant date | Sep 24, 2024 |
| Priority date | — |
| Expiry date | May 31, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4045
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition of psilocin that is stable including at least one agent or chemical modification that provides enhanced stability. A method making stable psilocin, by providing a formulation of psilocin including at least one agent or chemical modification that provides enhanced stability. A method of treatment of a disease or condition, by administering a composition of psilocin that is stable to an individual and treating the disease or condition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.